Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein

Virol J. 2007 Nov 20:4:123. doi: 10.1186/1743-422X-4-123.

Abstract

Background: Mechanisms by which HIV-1 mediates reductions in CD4+ cell levels in infected persons are being intensely investigated, and have broad implications for AIDS drug and vaccine development. Virally induced changes in membrane ionic permeability induced by lytic viruses of many families contribute to cytopathogenesis. HIV-1 induces disturbances in plasma membrane ion transport. The carboxyl terminus of TM (gp41) contains potential amphipathic alpha-helical motifs identified through their structural similarities to naturally occurring cytolytic peptides. These sequences have been dubbed lentiviral lytic peptides (LLP) -1, -2, and -3.

Results: Peptides corresponding to the LLP domains (from a clade B virus) partition into lipid membranes, fold into alpha-helices and disrupt model membrane permeability. A peptide corresponding to the LLP-1 domain of a clade D HIV-1 virus, LLP-1D displayed similar activity to the LLP-1 domain of the clade B virus in all assays, despite a lack of amino acid sequence identity.

Conclusion: These results suggest that the C-terminal domains of HIV-1 Env proteins may form an ion channel, or viroporin. Increased understanding of the function of LLP domains and their role in the viral replication cycle could allow for the development of novel HIV drugs.

MeSH terms

  • Amino Acid Motifs
  • Computational Biology
  • HIV Envelope Protein gp41 / chemistry*
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / metabolism
  • HIV-1 / chemistry
  • HIV-1 / genetics
  • HIV-1 / metabolism
  • Humans
  • Peptide Fragments / chemistry*
  • Peptide Fragments / metabolism
  • Peptides
  • Proteomics

Substances

  • HIV Envelope Protein gp41
  • Peptide Fragments
  • Peptides
  • lentiviral lytic peptide type 1, Human immunodeficiency virus 1